Weizhong Cai,Prakash Narayan,Bijoy Panicker,David E. Smith
申请号：
US16239836
公开号：
US20190375739A1
申请日:
2019.01.04
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides compositions and formulations of compounds having formula (I):and pharmaceutically acceptable derivatives thereof, wherein p, R1, R2 and B are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of injuries, conditions or diseases in which HGF/SF or the activities thereof, or agonists or antagonists thereof have a therapeutically useful role. In addition, methods are provided for treating such diseases or diseases starting at a time after the onset of the injury, condition or disease.
